Most affordable compounded semaglutide & tirzepatide in Illinois
⚠ Illinois legal details are prototype data — verify the Illinois Board of Pharmacy (IDFPR) link and current telehealth rules before publishing.
For Illinois residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Illinois generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Illinois must hold Illinois Board of Pharmacy (IDFPR) licensure, and the state's monitoring program is the Illinois PMP.
01Illinois rules that affect your access
- RXTelehealth visit standardIllinois generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
- PHPharmacy regulatorIllinois Board of Pharmacy (IDFPR) — idfpr.illinois.gov (verify link). Non-resident pharmacies shipping into Illinois must be licensed here.
- DBMonitoring programIllinois PMP.
- iState noteNon-resident pharmacy license required to ship into the state.
02Lowest-cost tirzepatide providers serving Illinois
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $186FLAT | $2,232 | |
| 2 | $99FLAT | $1,188 | |
| 3 | $130FLAT | $1,560 | |
| 4 | $149FLAT | $1,788 | |
| 5 | $179↑ | $2,148 |
03Lowest-cost semaglutide providers serving Illinois
| # | Provider | True/mo | 12-mo |
|---|---|---|---|
| ★ 1 | $145FLAT | $1,740 | |
| 2 | $280FLAT | $3,360 | |
| 3 | $99FLAT | $1,188 | |
| 4 | $120FLAT | $1,440 | |
| 5 | $149FLAT | $1,788 |
04Lowest fully-credentialed option in Illinois
NexLife
★★★★★ Compounded semaglutide + tirzepatide- MD/DO-supervised care
- 503A & 503B pharmacy network
- Labs included
- LegitScript-certified
- NABP-accredited pharmacy partners
- Flat rate, dose-independent
- Third-party batch testing
- Care360 coaching included
Editorial selection by our published rubric. We are not paid by NexLife and earn no commission from this link — see how this site works.
05Is compounded GLP-1 legal in Illinois in 2026?
Illinois follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Illinois.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →